-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Neurodegenerative Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-00114 in Neurodegenerative Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Neurodegenerative Diseases Drug Details: PT-00114 (TCAP-1) is under development for...
-
Thematic Analysis
NewBanking and Payments M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Banking & Payments Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Substance (Drug) Abuse
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-00114 in Substance (Drug) Abuse report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Substance (Drug) Abuse Drug Details: PT-00114 (TCAP-1) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Treatment Resistant Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-00114 in Treatment Resistant Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Treatment Resistant Depression Drug Details: PT-00114 (TCAP-1) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Generalized Anxiety Disorder (GAD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-00114 in Generalized Anxiety Disorder (GAD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Generalized Anxiety Disorder (GAD) Drug Details: PT-00114 (TCAP-1)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Post-Traumatic Stress Disorder (PTSD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-00114 in Post-Traumatic Stress Disorder (PTSD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Post-Traumatic Stress Disorder (PTSD) Drug Details: PT-00114 (TCAP-1)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imifoplatin in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imifoplatin in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imifoplatin in Ovarian Cancer Drug Details: PT-112 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imifoplatin in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imifoplatin in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imifoplatin in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: PT-112...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imifoplatin in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imifoplatin in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imifoplatin in Pancreatic Cancer Drug Details: PT-112 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imifoplatin in Thymoma (Thymic Epithelial Tumor)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imifoplatin in Thymoma (Thymic Epithelial Tumor) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imifoplatin in Thymoma (Thymic Epithelial Tumor) Drug Details: PT-112...